These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36229446)

  • 1. Anti-ANGPTL3-FLD monoclonal antibody treatment ameliorates podocyte lesions through attenuating mitochondrial damage.
    Lv Q; Han X; Ni J; Ma Q; Dai R; Liu J; Liu J; Zhai Y; Shen Q; Sun L; Liu H; Rao J; Xu H
    Cell Death Dis; 2022 Oct; 13(10):867. PubMed ID: 36229446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel role of angiopoietin-like-3 associated with podocyte injury.
    Liu J; Gao X; Zhai Y; Shen Q; Sun L; Feng C; Rao J; Liu H; Zha X; Guo M; Ma D; Zhang Z; Li R; Xu H
    Pediatr Res; 2015 Jun; 77(6):732-9. PubMed ID: 25710887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiopoietin-like-3 knockout protects against glomerulosclerosis in murine adriamycin-induced nephropathy by attenuating podocyte loss.
    Dai R; Liu H; Han X; Liu J; Zhai Y; Rao J; Shen Q; Xu H
    BMC Nephrol; 2019 May; 20(1):185. PubMed ID: 31126248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minnelide combined with anti-ANGPTL3-FLD monoclonal antibody completely protects mice with adriamycin nephropathy by promoting autophagy and inhibiting apoptosis.
    Ji B; Liu J; Yin Y; Xu H; Shen Q; Yu J
    Cell Death Dis; 2023 Sep; 14(9):601. PubMed ID: 37689694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A vital role for Angptl3 in the PAN-induced podocyte loss by affecting detachment and apoptosis in vitro.
    Dai R; Lin Y; Liu H; Rao J; Zhai Y; Zha X; Fang X; Xu H
    BMC Nephrol; 2015 Mar; 16():38. PubMed ID: 25884163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-proteinuria effect of antibody against ANGPTL3 coil-coiled domain on adriamycin-induced nephropathy in mice.
    Han X; Dai R; Zhai Y; Shen Q; Sun L; Liu H; Xu H
    Biochem Biophys Res Commun; 2019 Aug; 516(3):812-818. PubMed ID: 31256934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiopoietin-like protein 3 regulates the motility and permeability of podocytes by altering nephrin expression in vitro.
    Gao X; Xu H; Liu H; Rao J; Li Y; Zha X
    Biochem Biophys Res Commun; 2010 Aug; 399(1):31-6. PubMed ID: 20633534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of angiopoietin-like 3 associated with puromycin-induced podocyte damage.
    Jia R; Hong X; Li S; Haichun Y; Chuanming H
    Nephron Exp Nephrol; 2010; 115(3):e38-45. PubMed ID: 20424482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minnelide combined with Angptl3 knockout completely protects mice with adriamycin nephropathy via suppression of TGF-β1-Smad2 and p53 pathways.
    Ji B; Liu J; Ma Y; Yin Y; Xu H; Shen Q; Yu J
    Int Immunopharmacol; 2023 Feb; 115():109656. PubMed ID: 36608441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Podocyte protection by Angptl3 knockout via inhibiting ROS/GRP78 pathway in LPS-induced acute kidney injury.
    Ma Y; Liu J; Liu H; Han X; Sun L; Xu H
    Int Immunopharmacol; 2022 Apr; 105():108549. PubMed ID: 35086056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiopoietin-like 3 induces podocyte F-actin rearrangement through integrin α(V)β₃/FAK/PI3K pathway-mediated Rac1 activation.
    Lin Y; Rao J; Zha XL; Xu H
    Biomed Res Int; 2013; 2013():135608. PubMed ID: 24294595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiopoietin-like protein 3 modulates barrier properties of human glomerular endothelial cells through a possible signaling pathway involving phosphatidylinositol-3 kinase/protein kinase B and integrin alphaVbeta3.
    Li Y; Sun L; Xu H; Fang Z; Yao W; Guo W; Rao J; Zha X
    Acta Biochim Biophys Sin (Shanghai); 2008 Jun; 40(6):459-65. PubMed ID: 18535744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective role of cyclosporine A and minocycline on mitochondrial disequilibrium-related podocyte injury and proteinuria occurrence induced by adriamycin.
    Guan N; Ren YL; Liu XY; Zhang Y; Pei P; Zhu SN; Fan Q
    Nephrol Dial Transplant; 2015 Jun; 30(6):957-69. PubMed ID: 25646018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiopoietin-like protein 3 deficiency combined with valsartan administration protects better against podocyte damage in streptozotocin-induced diabetic nephropathy mice.
    Ma Y; Xie D; Liu J; Han X; Xu H; Chen Y
    Int Immunopharmacol; 2023 Feb; 115():109715. PubMed ID: 37724955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deiodinase-3 is a thyrostat to regulate podocyte homeostasis.
    Agarwal S; Koh KH; Tardi NJ; Chen C; Dande RR; WerneckdeCastro JP; Sudhini YR; Luongo C; Salvatore D; Samelko B; Altintas MM; Mangos S; Bianco A; Reiser J
    EBioMedicine; 2021 Oct; 72():103617. PubMed ID: 34649077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IP
    Xu H; Guan N; Ren YL; Wei QJ; Tao YH; Yang GS; Liu XY; Bu DF; Zhang Y; Zhu SN
    BMC Nephrol; 2018 Jun; 19(1):140. PubMed ID: 29907098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minnelide Markedly Reduces Proteinuria in Mice with Adriamycin Nephropathy by Protecting Against Podocyte Injury.
    Ji B; Liu J; Ma Y; Yin Y; Xu H; Shen Q; Yu J
    Appl Biochem Biotechnol; 2023 Dec; 195(12):7379-7396. PubMed ID: 37000351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel fusion protein consisting of anti-ANGPTL3 antibody and interleukin-22 ameliorates diabetic nephropathy in mice.
    Ma Q; Hu X; Liu F; Cao Z; Han L; Zhou K; Bai Y; Zhang Y; Nan Y; Lv Q; Rao J; Wu T; Yang X; He H; Ju D; Xu H
    Front Immunol; 2022; 13():1011442. PubMed ID: 36544775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein modulation of proteinuric renal injury.
    Tsuchida Y; Zhong J; Otsuka T; Dikalova A; Pastan I; Anantharamaiah GM; Linton MF; Yancey PG; Ikizler TA; Fogo AB; Yang H; Kon V
    Lab Invest; 2019 Jul; 99(8):1107-1116. PubMed ID: 31019291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Krüppel-like factor 15-NFATc1 axis ameliorates podocyte injury: a novel rationale for using glucocorticoids in proteinuria diseases.
    Dou C; Zhang H; Ke G; Zhang L; Lian Z; Chen X; Zhao X; Chen Y; Li R; Ma J; Li Z; Lin T; Wang W; Ye ZM; Liang X; Shi W; Zhang B; Liu S
    Clin Sci (Lond); 2020 Jun; 134(12):1305-1318. PubMed ID: 32478397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.